Log In
Print
BCIQ
Print
Print this Print this
 

ApoStream

  Manage Alerts
Collapse Summary General Information
Company ApoCell Inc.
DescriptionDetection device using dielectrophoresis field flow fractionation to isolate and recover circulating tumor cells (CTCs)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase III
Standard IndicationCancer, Diagnostic
Indication DetailsEarly detection of hepatocellular carcinoma (HCC); Identify EGFR mutations in CTCs from non-small cell lung cancer (NSCLC) patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today